Glutamine inhibits lipopolysaccharide-induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse

Young Suk Kim, Gi Young Kim, Jae-Hong Kim, Hye Jin You, Young Min Park, Hern Ku Lee, Hee Chul Yu, Mo Chung Sung, Zhe Wu Jin, Hyun Mi Ko, Baik Hwan Cho

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Glutamine (Gln) supplementation is known to play a beneficial role in a number of settings of critical illness as well as laboratory models of endotoxin shock. We have investigated a molecular mechanism of the protective role of Gln in lipopolysaccharide (LPS)-induced shock using a mouse model. To examine the effectiveness of Gln, Gln was administered before or after LPS injection. Treatment of Gln before, but not after, LPS injection resulted in inhibition of nuclear factor κB activation and tumor necrosis factor α synthesis. In contrast, protection of animal from LPS-mediated death by Gln was observed when the Gln treatment was performed after LPS injection, suggesting that nuclear factor κB/tumor necrosis factor α signaling does not play an important role in this process. LPS injection induced phosphorylation of cytoplasmic phospholipase A2 (cPLA2), which was blocked by Gln treatment after LPS injection. Similarly, the LPS-stimulated cPLA 2 activity was also inhibited by Gln treatment after LPS injection. Moreover, a cPLA2 inhibitor not only inhibited LPS-induced activation of cPLA2, but also significantly prevented LPS-mediated death. These observations indicate that Gln has a capability to inhibit cPLA2 phosphorylation and activation and suggest that Gln might be of a great therapeutic value for controlling inflammatory diseases in which cPLA 2 plays an important role in the pathogenesis of the diseases.

Original languageEnglish
Pages (from-to)291-295
Number of pages5
JournalShock
Volume25
Issue number3
DOIs
Publication statusPublished - 2006 Mar 1

Fingerprint

Phospholipases A2
Glutamine
Endotoxins
Lipopolysaccharides
Shock
Injections
Tumor Necrosis Factor-alpha
Phosphorylation
Therapeutics
Critical Illness

Keywords

  • Arachidonyltrifluoromethyl ketone
  • Endotoxin
  • Glutamine
  • Lipopolysaccharide
  • Phospholipase A
  • Shock

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Physiology

Cite this

Glutamine inhibits lipopolysaccharide-induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse. / Kim, Young Suk; Kim, Gi Young; Kim, Jae-Hong; You, Hye Jin; Park, Young Min; Lee, Hern Ku; Yu, Hee Chul; Sung, Mo Chung; Jin, Zhe Wu; Ko, Hyun Mi; Cho, Baik Hwan.

In: Shock, Vol. 25, No. 3, 01.03.2006, p. 291-295.

Research output: Contribution to journalArticle

Kim, YS, Kim, GY, Kim, J-H, You, HJ, Park, YM, Lee, HK, Yu, HC, Sung, MC, Jin, ZW, Ko, HM & Cho, BH 2006, 'Glutamine inhibits lipopolysaccharide-induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse', Shock, vol. 25, no. 3, pp. 291-295. https://doi.org/10.1097/01.shk.0000194041.18699.6f
Kim, Young Suk ; Kim, Gi Young ; Kim, Jae-Hong ; You, Hye Jin ; Park, Young Min ; Lee, Hern Ku ; Yu, Hee Chul ; Sung, Mo Chung ; Jin, Zhe Wu ; Ko, Hyun Mi ; Cho, Baik Hwan. / Glutamine inhibits lipopolysaccharide-induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse. In: Shock. 2006 ; Vol. 25, No. 3. pp. 291-295.
@article{209a5b6d496e44be984edf860dc35cdb,
title = "Glutamine inhibits lipopolysaccharide-induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse",
abstract = "Glutamine (Gln) supplementation is known to play a beneficial role in a number of settings of critical illness as well as laboratory models of endotoxin shock. We have investigated a molecular mechanism of the protective role of Gln in lipopolysaccharide (LPS)-induced shock using a mouse model. To examine the effectiveness of Gln, Gln was administered before or after LPS injection. Treatment of Gln before, but not after, LPS injection resulted in inhibition of nuclear factor κB activation and tumor necrosis factor α synthesis. In contrast, protection of animal from LPS-mediated death by Gln was observed when the Gln treatment was performed after LPS injection, suggesting that nuclear factor κB/tumor necrosis factor α signaling does not play an important role in this process. LPS injection induced phosphorylation of cytoplasmic phospholipase A2 (cPLA2), which was blocked by Gln treatment after LPS injection. Similarly, the LPS-stimulated cPLA 2 activity was also inhibited by Gln treatment after LPS injection. Moreover, a cPLA2 inhibitor not only inhibited LPS-induced activation of cPLA2, but also significantly prevented LPS-mediated death. These observations indicate that Gln has a capability to inhibit cPLA2 phosphorylation and activation and suggest that Gln might be of a great therapeutic value for controlling inflammatory diseases in which cPLA 2 plays an important role in the pathogenesis of the diseases.",
keywords = "Arachidonyltrifluoromethyl ketone, Endotoxin, Glutamine, Lipopolysaccharide, Phospholipase A, Shock",
author = "Kim, {Young Suk} and Kim, {Gi Young} and Jae-Hong Kim and You, {Hye Jin} and Park, {Young Min} and Lee, {Hern Ku} and Yu, {Hee Chul} and Sung, {Mo Chung} and Jin, {Zhe Wu} and Ko, {Hyun Mi} and Cho, {Baik Hwan}",
year = "2006",
month = "3",
day = "1",
doi = "10.1097/01.shk.0000194041.18699.6f",
language = "English",
volume = "25",
pages = "291--295",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Glutamine inhibits lipopolysaccharide-induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse

AU - Kim, Young Suk

AU - Kim, Gi Young

AU - Kim, Jae-Hong

AU - You, Hye Jin

AU - Park, Young Min

AU - Lee, Hern Ku

AU - Yu, Hee Chul

AU - Sung, Mo Chung

AU - Jin, Zhe Wu

AU - Ko, Hyun Mi

AU - Cho, Baik Hwan

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Glutamine (Gln) supplementation is known to play a beneficial role in a number of settings of critical illness as well as laboratory models of endotoxin shock. We have investigated a molecular mechanism of the protective role of Gln in lipopolysaccharide (LPS)-induced shock using a mouse model. To examine the effectiveness of Gln, Gln was administered before or after LPS injection. Treatment of Gln before, but not after, LPS injection resulted in inhibition of nuclear factor κB activation and tumor necrosis factor α synthesis. In contrast, protection of animal from LPS-mediated death by Gln was observed when the Gln treatment was performed after LPS injection, suggesting that nuclear factor κB/tumor necrosis factor α signaling does not play an important role in this process. LPS injection induced phosphorylation of cytoplasmic phospholipase A2 (cPLA2), which was blocked by Gln treatment after LPS injection. Similarly, the LPS-stimulated cPLA 2 activity was also inhibited by Gln treatment after LPS injection. Moreover, a cPLA2 inhibitor not only inhibited LPS-induced activation of cPLA2, but also significantly prevented LPS-mediated death. These observations indicate that Gln has a capability to inhibit cPLA2 phosphorylation and activation and suggest that Gln might be of a great therapeutic value for controlling inflammatory diseases in which cPLA 2 plays an important role in the pathogenesis of the diseases.

AB - Glutamine (Gln) supplementation is known to play a beneficial role in a number of settings of critical illness as well as laboratory models of endotoxin shock. We have investigated a molecular mechanism of the protective role of Gln in lipopolysaccharide (LPS)-induced shock using a mouse model. To examine the effectiveness of Gln, Gln was administered before or after LPS injection. Treatment of Gln before, but not after, LPS injection resulted in inhibition of nuclear factor κB activation and tumor necrosis factor α synthesis. In contrast, protection of animal from LPS-mediated death by Gln was observed when the Gln treatment was performed after LPS injection, suggesting that nuclear factor κB/tumor necrosis factor α signaling does not play an important role in this process. LPS injection induced phosphorylation of cytoplasmic phospholipase A2 (cPLA2), which was blocked by Gln treatment after LPS injection. Similarly, the LPS-stimulated cPLA 2 activity was also inhibited by Gln treatment after LPS injection. Moreover, a cPLA2 inhibitor not only inhibited LPS-induced activation of cPLA2, but also significantly prevented LPS-mediated death. These observations indicate that Gln has a capability to inhibit cPLA2 phosphorylation and activation and suggest that Gln might be of a great therapeutic value for controlling inflammatory diseases in which cPLA 2 plays an important role in the pathogenesis of the diseases.

KW - Arachidonyltrifluoromethyl ketone

KW - Endotoxin

KW - Glutamine

KW - Lipopolysaccharide

KW - Phospholipase A

KW - Shock

UR - http://www.scopus.com/inward/record.url?scp=33646797447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646797447&partnerID=8YFLogxK

U2 - 10.1097/01.shk.0000194041.18699.6f

DO - 10.1097/01.shk.0000194041.18699.6f

M3 - Article

VL - 25

SP - 291

EP - 295

JO - Shock

JF - Shock

SN - 1073-2322

IS - 3

ER -